AML Archives - Page 3 of 3 - Together4Cancer Compass

Skip to content

Patients

HCPs

X-twitter Instagram Youtube Icon-mail Tiktok

Home

Categories

Breast Cancer (31)
Cancers of the Lymphatic System (9)
Digestive (CRC, Stomach) System (37)
Endocrine (Thyroid) System (1)
Genitourinary (Prostate, Bladder) System (5)
Gynecologic Cancer (1)
Head & Neck Cancers (1)
Hematologic Cancers (31)
Melanoma (1)
Pan Cancer (12)
Patient Communication (1)
Reproductive System (3)
Respiratory (Lung, Bronchus) System (38)
Supportive Oncology (21)
Survivorship (7)

Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology).

Post category:Hematologic Cancers
Reading time:1 min read

This study analyzed 2,823 adult AML patients from the US and Germany, assessing molecular genetic features and outcomes...

Continue ReadingMulti-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology).

Thiotepa-busulfan-fludarabine compared to clofarabine-based conditioning for haploidentical transplant with posttransplant cyclophosphamide in patients with myeloid malignancies: a retrospective study from the SFGM-TC.

Post category:Hematologic Cancers
Reading time:1 min read

The study retrospectively compared two reduced-intensity conditioning (RIC) regimens, Clofarabine-Baltimore (CloB) and T...

Continue ReadingThiotepa-busulfan-fludarabine compared to clofarabine-based conditioning for haploidentical transplant with posttransplant cyclophosphamide in patients with myeloid malignancies: a retrospective study from the SFGM-TC.

© Together4Cancer. All rights reserved.

Privacy Policy
Terms of Use